U.S. Rep. Abigail Spanberger (D-Va.) has been in close contact with 340B covered entity organizations to explore the implications of Express Scripts’ actions on 340B covered entities, her office told 340B Report this afternoon.
Opposition to Express Scripts’ 340B Claims ID Requirement Grows
Legislation addressing pharmacy benefit manager Express Scripts’ (ESI) new claims identification requirement for 340B drugs could be introduced in Congress soon, advisers to 340B covered entities said yesterday.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
